Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 May 23;20(10):1485–1492. doi: 10.1016/j.bbmt.2014.05.015

Table 1.

The 3-year probabilities of non-relapse mortailty, relapse, progression-free and overall survival

Donor Type
Double umbilical cord blood
BMT CTN 0604
Haploidentical bone marrow
BMT CTN 0603
Non-relapse mortality 28% (95% CI 15 – 41) 8% (95% CI 0.4 – 16)
Relapse 36% (95% CI 23 – 50) 58% (95% CI 43 – 72)
Progression-free survival 36% (95% CI 23 – 49) 35% (95% CI 21 – 48)
Overall survival 39% (95% CI 26 – 53) 54% (95% CI 39 – 67)